Literature DB >> 3211432

White cells radiolabelled with 111In and 99Tcm--a study of relative sensitivity and in vivo viability.

D C Costa1, D Lui, P J Ell.   

Abstract

In this study a comparison between the classical (111In oxine) and the newer (99Tcm HMPAO) technique of labelling leucocytes is reported. The behaviour in vivo and the relative sensitivity in the detection of infection (chest and bone) and inflammatory bowel disease (IBD) is presented. Simultaneous dual-radionuclide gamma camera acquisition methodology was applied to study 99 patients, 18 with chest infection, 26 with bone infection, 41 with IBD and 14 with other pathological conditions. The mean (1 SD) 50% washout time from the lungs was 483.03 (79.10) s for 99Tcm HMPAO-labelled white blood cells and 475.85 (83.79) s for 111In oxine-labelled white cells (r = 0.81). Concordance between the two techniques was 94% in the chest-infection group of patients, 88% in the bone-infection group and 71% in the localization of IBD.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3211432     DOI: 10.1097/00006231-198810000-00009

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  12 in total

1.  Visualising E-selectin in the detection and evaluation of inflammatory bowel disease.

Authors:  M Bhatti; P Chapman; M Peters; D Haskard; H J Hodgson
Journal:  Gut       Date:  1998-07       Impact factor: 23.059

2.  Inflammatory bowel disease activity assessment using technetium-99m-HMPAO leukocytes.

Authors:  J W Arndt; M I Grootscholten; R A van Hogezand; G Griffioen; C B Lamers; E K Pauwels
Journal:  Dig Dis Sci       Date:  1997-02       Impact factor: 3.199

3.  99mTc-human immunoglobulin (HIG)--first results of a new agent for the localization of infection and inflammation.

Authors:  J R Buscombe; D Lui; G Ensing; R de Jong; P J Ell
Journal:  Eur J Nucl Med       Date:  1990

4.  Comparison of simultaneous 99mTc-HMPAO and 111In oxine labelled white cell scans in the assessment of inflammatory bowel disease.

Authors:  R A Allan; G E Sladen; S Bassingham; C Lazarus; S E Clarke; I Fogelman
Journal:  Eur J Nucl Med       Date:  1993-03

5.  Labelled leucocyte scintigraphy in inflammatory bowel disease: clinical applications.

Authors:  M H Giaffer
Journal:  Gut       Date:  1996-01       Impact factor: 23.059

6.  99mTc labeling white blood cells with a simple technique: clinical application.

Authors:  B Gutfilen; M P Pellini; J de Roure e Neder; J L de Amarante Júnior; M G Evangelista; S R Fernandes; M Bernardo-Filho
Journal:  Ann Nucl Med       Date:  1994-02       Impact factor: 2.668

7.  Value of positive technetium-99m leucocyte scans in predicting intestinal inflammation.

Authors:  P Gibson; M Lichtenstein; N Salehi; G Hebbard; J Andrews
Journal:  Gut       Date:  1991-12       Impact factor: 23.059

8.  Autoradiography and density gradient separation of technetium-99m-exametazime (HMPAO) labelled leucocytes reveals selectivity for eosinophils.

Authors:  M R Puncher; P J Blower
Journal:  Eur J Nucl Med       Date:  1994-11

9.  Technetium-99m scintigraphy: more accurate assessment of ulcerative colitis with exametazime-labelled leucocytes than with antigranulocyte antibodies.

Authors:  S Almers; G Granerus; L Franzén; M Ström
Journal:  Eur J Nucl Med       Date:  1996-03

10.  Technetium-99m and indium-111 double labelling of granulocytes for kinetic and clinical studies.

Authors:  C Aktolun; W Y Ussov; A Arka; D Glass; R D Gunasekera; A M Peters
Journal:  Eur J Nucl Med       Date:  1995-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.